Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hofseth Biocare ASA ( (HOFBF) ) has provided an update.
Hofseth BioCare ASA has announced the completion of a private placement of new shares, pending approval at an extraordinary general meeting. This move is expected to support the company’s growth and innovation in health products derived from salmon by-products, potentially enhancing its market position and benefiting stakeholders.
More about Hofseth Biocare ASA
Hofseth BioCare ASA is a Norwegian company specializing in consumer and pet health products, focusing on sustainability and the optimal use of natural resources. The company converts salmon industry by-products into health-enhancing ingredients such as bioactive peptides, salmon oil, and bone powder, with proven benefits in iron metabolism, immune health, and bone and joint health. HBC is headquartered in Ålesund, Norway, with international branches and is listed on the Oslo Stock Exchange.
Average Trading Volume: 96,863
Current Market Cap: NOK822.2M
See more data about HOFBF stock on TipRanks’ Stock Analysis page.